Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
9 | 136523954 | stop gained | G/A | snv | 6.2E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 0.700 | 1.000 | 19 | 1999 | 2019 | |||||||||
|
9 | 136499244 | stop gained | G/A | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 0.700 | 1.000 | 19 | 1999 | 2019 | ||||||||||
|
9 | 136500595 | missense variant | G/A | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||||
|
9 | 136500595 | missense variant | G/A | snv |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||||
|
9 | 136498710 | intron variant | G/A | snv | 0.55 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
9 | 136498710 | intron variant | G/A | snv | 0.55 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
9 | 136507052 | intron variant | G/A | snv | 0.57 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
9 | 136494732 | 3 prime UTR variant | A/G | snv | 0.51 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
9 | 136514670 | missense variant | C/T | snv | 2.0E-05 | 7.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
9 | 136514670 | missense variant | C/T | snv | 2.0E-05 | 7.0E-06 |
|
Skin and Connective Tissue Diseases | 0.700 | 0 | |||||||||||
|
0.827 | 0.120 | 9 | 136495945 | 3 prime UTR variant | C/T | snv | 0.62 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.827 | 0.120 | 9 | 136495945 | 3 prime UTR variant | C/T | snv | 0.62 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.827 | 0.120 | 9 | 136495945 | 3 prime UTR variant | C/T | snv | 0.62 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.827 | 0.120 | 9 | 136495945 | 3 prime UTR variant | C/T | snv | 0.62 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.827 | 0.120 | 9 | 136495945 | 3 prime UTR variant | C/T | snv | 0.62 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.827 | 0.120 | 9 | 136495945 | 3 prime UTR variant | C/T | snv | 0.62 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.827 | 0.120 | 9 | 136494980 | 3 prime UTR variant | C/T | snv | 3.0E-02 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.827 | 0.120 | 9 | 136494980 | 3 prime UTR variant | C/T | snv | 3.0E-02 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.827 | 0.120 | 9 | 136494980 | 3 prime UTR variant | C/T | snv | 3.0E-02 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.827 | 0.120 | 9 | 136494980 | 3 prime UTR variant | C/T | snv | 3.0E-02 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.827 | 0.120 | 9 | 136494980 | 3 prime UTR variant | C/T | snv | 3.0E-02 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.080 | 9 | 136509318 | intron variant | G/A | snv | 0.13 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.080 | 9 | 136509318 | intron variant | G/A | snv | 0.13 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | < 0.001 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.080 | 9 | 136509318 | intron variant | G/A | snv | 0.13 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.851 | 0.080 | 9 | 136509318 | intron variant | G/A | snv | 0.13 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | < 0.001 | 1 | 2017 | 2017 |